Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Sales: 2009-2025

Historic Return on Sales for Aytu Biopharma (AYTU) over the last 16 years, with Sep 2025 value amounting to 0.03%.

  • Aytu Biopharma's Return on Sales rose 7.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 7.00%. This contributed to the annual value of 0.01% for FY2025, which is 6.00% up from last year.
  • As of Q3 2025, Aytu Biopharma's Return on Sales stood at 0.03%, which was up 270.47% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Return on Sales ranged from a high of 0.03% in Q3 2025 and a low of -1.20% during Q1 2022.
  • Moreover, its 3-year median value for Return on Sales was -0.05% (2024), whereas its average is -0.08%.
  • In the last 5 years, Aytu Biopharma's Return on Sales tumbled by 55bps in 2021 and then spiked by 97bps in 2023.
  • Over the past 5 years, Aytu Biopharma's Return on Sales (Quarterly) stood at -1.02% in 2021, then climbed by 29bps to -0.73% in 2022, then skyrocketed by 60bps to -0.13% in 2023, then climbed by 10bps to -0.02% in 2024, then grew by 7bps to 0.03% in 2025.
  • Its Return on Sales stands at 0.03% for Q3 2025, versus 0.01% for Q2 2025 and -0.01% for Q1 2025.